A Randomized, Double-Blind, Placebo-Controlled, Pilot Study to Assess the Safety and Efficacy of NVXT Solution in Patients With Mild-to-Moderate Fungal Infection of the Toe Nail
Phase of Trial: Phase II
Latest Information Update: 10 May 2017
At a glance
- Drugs NP 213 (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- Sponsors Taro Pharmaceuticals USA
- 19 Apr 2016 Status changed from active, no longer recruiting to completed.
- 02 Nov 2015 Planned End Date changed from 1 Dec 2015 to 1 Jan 2016, according to ClinicalTrials.gov record.
- 02 Nov 2015 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.